Company Filing History:
Years Active: 2013-2025
Title: Garth Campbell Sutherland: Innovator in Medicament Inhaler Technology
Introduction
Garth Campbell Sutherland is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of medicament inhalers, holding a total of 16 patents. His innovative designs focus on improving patient adherence and monitoring in the use of inhalers.
Latest Patents
One of his latest patents is the "Releasable monitor with optical dose counter for a medicament inhaler." This device is designed to monitor patient usage of a medicament inhaler and includes a housing for releasable attachment to the inhaler. It features a sensor that determines when a dose has been dispensed, and it operates without requiring modifications to the inhaler itself. Additionally, the device may include an electronic control module that communicates with the sensor to monitor and store data related to patient usage.
Another significant patent is the "Adherence monitor for a medicament inhaler with tethered cap." This adherence monitor engages with a tethered cap inhaler device and includes a tether opening within its housing. The design ensures that the tether's path length remains unchanged when the monitor is attached, allowing for accurate detection of inhaler usage through various sensors.
Career Highlights
Throughout his career, Garth has worked with companies such as Adherium Limited and Nexus6 Limited. His work has focused on developing technologies that enhance the functionality and usability of medicament inhalers, ultimately aiming to improve patient outcomes.
Collaborations
Garth has collaborated with notable individuals in the field, including Michael James Gormack and Benjamin Lance Catt. These collaborations have contributed to the advancement of inhaler technology and patient adherence solutions.
Conclusion
Garth Campbell Sutherland is a prominent inventor whose work in medicament inhaler technology has led to significant advancements in patient monitoring and adherence. His innovative patents reflect a commitment to improving healthcare solutions for patients who rely on inhalers.